Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain ...
By Mariam Sunny Jan 13 (Reuters) - The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential ...
This article was reviewed by Lynn Marie Morski, MD, JD Key Takeaways: Peptides are compounds made of amino acids linked by ...
The FDA said it wants suicide warnings to be taken off some popular weight-loss medications following a comprehensive safety ...
Agency officials say a comprehensive review “found no increased risk” related to suicide among users of the GLP-1 drugs used ...
As the demand for affordable healthcare options grows, the pharmaceutical industry is increasingly focused on developing generic drugs to expand access and reduce costs. This trend is driving major ...
(CNN)– The Food and Drug Administration (FDA) wants suicide warnings to be taken off of some popular weight-loss medications.